Emily Schwenger
Albert Einstein College of Medicine(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Genomics and Chromatin Dynamics, Glycosylation and Glycoproteins Research, Proteoglycans and glycosaminoglycans research
Most-Cited Works
- → Harnessing Meta‐analysis to Refine an Oncology Patient Population for Physiology‐Based Pharmacokinetic Modeling of Drugs(2017)51 cited
- → MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism(2021)33 cited
- → Functional interaction of Rpb1 and Spt5 C-terminal domains in co-transcriptional histone modification(2015)24 cited
- → Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity(2024)16 cited
- → An Evolutionary Approach to Clonally Complex Hematologic Disorders(2021)10 cited
- → A glycan-based approach to cell characterization and isolation: Hematopoiesis as a paradigm(2022)10 cited
- → Transcription Factor Redistributors Pharmacologically Actuate Non-Canonical Gene Networks to Drive AML Differentiation(2023)1 cited
- → Mechanisms of Cistromic Repositioning of the Transcription Factor PU.1(2022)
- → 2022 – TRANSCRIPTION FACTOR REDISTRIBUTORS ACTUATE NON-CANONICAL GENE CIRCUITS TO DRIVE AML DIFFERENTIATION(2023)
- → 2020 – DIRECT PHARMACOLOGICAL REDISTRIBUTION OF THE MASTER TRANSCRIPTION FACTOR PU.1(2022)